FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W257094950> ?p ?o ?g. }

• W257094950 endingPage "56" @default.
• W257094950 startingPage "52" @default.
• W257094950 abstract "1. Nicholas M. Moore, MS, MLS(ASCP)[⇑][1] 1. Rush University, Department of Medical Laboratory Science, Chicago, IL 2. Maribeth L. Flaws, PhD, SM(ASCP)SI 1. Rush University, Department of Medical Laboratory Science, Chicago, IL <!-- --> 1. Address for Correspondence: Nicholas M. Moore, MS, MLS (ASCP), Department of Medical Laboratory Science, 600 S. Paulina St., Suite 1014, Chicago, IL 60612, 312-942-2111, Fax: (312) 942-6464, Nicholas_Moore{at}rush.edu 1. Describe the mechanism of action of the primary anti-pseudomonal agents. 2. List the advantages and disadvantages of combination drug therapy. 3. List the advantages and disadvantages of mono drug therapy. 4. Determine which antibiotic combinations are appropriate for treatment of various infections caused by Pseudomonas aeruginosa . Pseudomonas aeruginosa is a common cause of infection, especially hospital-acquired infections. It is opportunistic, more often causing infection in immunocom-promised hosts and it is often antibiotic resistant, complicating the efficacy of therapy. These factors have increased the number of patients infected with P. aeruginosa , increased the severity of those infections, and caused a great deal of conflict amongst infectious disease practitioners on how to appropriately and effectively manage their treatment. The following sections will describe appropriate treatment regimens for non-cystic fibrosis patients with infections caused by P. aeruginosa and discuss empiric as well as mono versus combination therapy protocols. Anti-Pseudomonas Antibiotics The antimicrobial agents listed in Table 1 have activity against P. aeruginosa . Beta Lactams Beta-lactams are a broad group of antibiotics that include penicillins, cephalosporins, monobactams and carbapenems. At the molecular level, the beta-lactams have thiazolidine and beta-lactam rings to which is attached a side chain. Beta-lactams are one of the most widely prescribed antibiotic agents in the United States. They are bactericidal and act by binding to transpeptidases [also known as penicillin-binding proteins (PBP)] thereby interfering with the synthesis of the peptidoglycan layer of the cell wall. Bacteria, including P. aeruginosa , become resistant to beta-lactams by either possessing enzymes (beta-lactamases) that hydrolyze the beta-lactam ring or altering the PBPs such that the antimicrobial agent can no longer bind and exert its effect. The beta-lactams that have the most activity against P. aeruginosa include piperacillin, ticarcillin, 3rd and 4th generation cephalosporins (ceftazidime and cefepime respectfully), and carbapenems like imipenem… ABBREVIATIONS: DNA = Deoxyribonucleic Acid, IDSA = Infectious Disease Society of America, ATS = American Thoracic Society. 1. Describe the mechanism of action of the primary anti-pseudomonal agents. 2. List the advantages and disadvantages of combination drug therapy. 3. List the advantages and disadvantages of mono drug therapy. 4. Determine which antibiotic combinations are appropriate for treatment of various infections caused by Pseudomonas aeruginosa . [1]: #corresp-1" @default.
• W257094950 created "2016-06-24" @default.
• W257094950 creator A5053236327 @default.
• W257094950 creator A5070487088 @default.
• W257094950 date "2011-01-01" @default.
• W257094950 modified "2023-10-01" @default.
• W257094950 title "Treatment Strategies and Recommendations for Pseudomonas aeruginosa Infections" @default.
• W257094950 doi "https://doi.org/10.29074/ascls.24.1.52" @default.
• W257094950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21404966" @default.
• W257094950 hasPublicationYear "2011" @default.
• W257094950 type Work @default.
• W257094950 sameAs 257094950 @default.
• W257094950 citedByCount "8" @default.
• W257094950 countsByYear W2570949502013 @default.
• W257094950 countsByYear W2570949502015 @default.
• W257094950 countsByYear W2570949502016 @default.
• W257094950 countsByYear W2570949502019 @default.
• W257094950 countsByYear W2570949502022 @default.
• W257094950 countsByYear W2570949502023 @default.
• W257094950 crossrefType "journal-article" @default.
• W257094950 hasAuthorship W257094950A5053236327 @default.
• W257094950 hasAuthorship W257094950A5070487088 @default.
• W257094950 hasBestOaLocation W2570949501 @default.
• W257094950 hasConcept C126322002 @default.
• W257094950 hasConcept C177713679 @default.
• W257094950 hasConcept C2776938444 @default.
• W257094950 hasConcept C2777637488 @default.
• W257094950 hasConcept C2779134260 @default.
• W257094950 hasConcept C2779181126 @default.
• W257094950 hasConcept C4937899 @default.
• W257094950 hasConcept C501593827 @default.
• W257094950 hasConcept C523546767 @default.
• W257094950 hasConcept C524204448 @default.
• W257094950 hasConcept C54355233 @default.
• W257094950 hasConcept C64778159 @default.
• W257094950 hasConcept C71924100 @default.
• W257094950 hasConcept C86803240 @default.
• W257094950 hasConcept C89423630 @default.
• W257094950 hasConceptScore W257094950C126322002 @default.
• W257094950 hasConceptScore W257094950C177713679 @default.
• W257094950 hasConceptScore W257094950C2776938444 @default.
• W257094950 hasConceptScore W257094950C2777637488 @default.
• W257094950 hasConceptScore W257094950C2779134260 @default.
• W257094950 hasConceptScore W257094950C2779181126 @default.
• W257094950 hasConceptScore W257094950C4937899 @default.
• W257094950 hasConceptScore W257094950C501593827 @default.
• W257094950 hasConceptScore W257094950C523546767 @default.
• W257094950 hasConceptScore W257094950C524204448 @default.
• W257094950 hasConceptScore W257094950C54355233 @default.
• W257094950 hasConceptScore W257094950C64778159 @default.
• W257094950 hasConceptScore W257094950C71924100 @default.
• W257094950 hasConceptScore W257094950C86803240 @default.
• W257094950 hasConceptScore W257094950C89423630 @default.
• W257094950 hasIssue "1" @default.
• W257094950 hasLocation W2570949501 @default.
• W257094950 hasLocation W2570949502 @default.
• W257094950 hasOpenAccess W257094950 @default.
• W257094950 hasPrimaryLocation W2570949501 @default.
• W257094950 hasRelatedWork W2038138310 @default.
• W257094950 hasRelatedWork W2065273123 @default.
• W257094950 hasRelatedWork W2282490712 @default.
• W257094950 hasRelatedWork W2616191535 @default.
• W257094950 hasRelatedWork W3032865068 @default.
• W257094950 hasRelatedWork W3046721888 @default.
• W257094950 hasRelatedWork W3132092684 @default.
• W257094950 hasRelatedWork W3169434034 @default.
• W257094950 hasRelatedWork W4292552678 @default.
• W257094950 hasRelatedWork W774948094 @default.
• W257094950 hasVolume "24" @default.
• W257094950 isParatext "false" @default.
• W257094950 isRetracted "false" @default.
• W257094950 magId "257094950" @default.
• W257094950 workType "article" @default.